RARRES2 and clear cell renal carcinoma: In a mouse model of clear cell renal carcinoma, for example, inhibition of chemerin by an anti-chemerin antibody improves outcomes via both chem1 and chem2 that, in turn, regulates lipid metabolism [14,62].